or Try an Advanced Search...

    Portola Pharmaceuticals Stocks List

    Symbol Grade Name % Change
    RIGL F Rigel Pharmaceuticals, Inc. -5.41
    BIIB F Biogen Idec Inc. -0.85
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Lupus Adenosine Alzheimer's Disease Asthma Autoimmune Disease Autoimmune Disorders Biotechnology Cancer Cancer Cell Cd20 Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Product Clinical Trial Products Daiichi Sankyo Degenerative Disease Disability Discoid Lupus Drug Development Enzymes

    Related ETFs - A few ETFs which own one or more of the above listed Portola Pharmaceuticals stocks.

    Symbol Grade Name Weight
    BIS A ProShares UltraShort Nasdaq Biotechnology 6.12
    PBE D PowerShares Dynamic Biotech & Genome 4.73
    DIP B BTD Capital Fund 4.41
    BBH D Market Vectors Biotech ETF 4.32
    IBRN D iShares Neuroscience and Healthcare ETF 4.14
    View all Portola Pharmaceuticals ETFs...
    Compare ETFs
    Compare BIS to IBRN Compare DIP to IBRN Compare PBE to BBH

        Portola Pharmaceuticals Stocks Recent News

        Date Stock Title
        Apr 17 BIIB Biogen Inc. (BIIB) Reports Next Week: Wall Street Expects Earnings Growth
        Apr 16 BIIB Biogen’s Alzheimer's drug to cost $3.5B for Medicare in 2025: report
        Apr 12 BIIB GLP-1s benefit Parkinson’s: Barclays sees implications across biopharma
        Apr 12 BIIB Biogen Is Suffering From Doubts About the Future
        Apr 12 RIGL Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Lupus Adenosine Alzheimer's Disease Asthma Autoimmune Disease Autoimmune Disorders Biotechnology Cancer Cancer Cell Cd20 Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Product Clinical Trial Products Daiichi Sankyo Degenerative Disease Disability Discoid Lupus Drug Development Enzymes
        Portola Pharmaceuticals

        Portola Pharmaceuticals is an American clinical stage biotechnology company that researches, develops and commercializes drugs. The company focuses primarily on drugs used in the treatment of thrombosis and hematological malignancies.
        Headquartered and founded in South San Francisco, California, Portola Pharmaceuticals is a member of the NASDAQ Biotechnology Index.

        More about Portola Pharmaceuticals
        Browse All Tags